GEN Exclusives

More »

Feb. 15, Vol. 26, No. 4

    • Point of View

      • In Support of Animal Study Management Software
      • Every drug candidate undergoes efficacy and preliminary safety tests in animals, which constitute the critical bottleneck in the pivotal decision process of whether to pursue full-scale preclinical development. Remarkably, almost all of these animal ... more »
      • In Silico Tools Streamline Drug Design
      • Gail Dutton
      • LigandScout, released this month by Inte:Ligand (www.inteligand. com), features a 3-D pharmacophore modeling approach that, according to Inte:Ligand, offers significant time savings when compared to ligand docking. A pharmacophore search for million ... more »
      • Large-Scale Production of Antibodies
      • Antibody processing is a complex field, demanding an understanding of bioengineering, equipment design, cell genetics, and cell culture technology. As demands for large-scale antibody production levels become more intense, companies are pursuing the ... more »
      • Ready-to-Play Assays, Kits, and Libraries
      • When you go to the grocery store these days, its all about convenience. Food is precooked and prepackaged into meals, so you can spend time doing other things. Perhaps then, it is no surprise that similar trends are occurring in life sciences suppor ... more »
      • Target Identification Methods Advance
      • Elizabeth Lipp
      • Spring is coming, and GENs thoughts have turned to target identification and the IBC confabs that will coincide with the vernal equinox. Screening to Analysis will offer talks and panels about advancing targets from discovery to lead optimization to ... more »
      • Tracking Diseases at the Molecular Level
      • Sophia Fox
      • A proprietary technology utilizing transmission electron microscopy (TEM) to obtain detailed 3-D images of the conformation of individual proteins and macromolecular complexes in biological samples is providing what Sidec Technologies ( ... more »
    • Tutorials

      • Assay: Miniaturized Cellular Assays
      • Gprotein-coupled receptors (GPCRs) are an important class of receptor in modern drug discovery. This superfamily of receptors is highly tractable for drug discovery purposes because many of these receptors are coupled (via Gaq/11) to transient relea ... more »
      • Next-Generation RNA Interference
      • The technology of RNA interference has rapidly evolved as a revolutionary tool for studying gene function, biological pathways, and the physiology of disease. Work and refinement of the RNAi technology has exploded in recent years. We now know the b ... more »
      • Optimizing Bacterial Cell Processing
      • Bacterial cells are widely used for production of various therapeutic proteins. Isolating these valuable proteins from the other material in the culture media and refolding them into their active configuration are critical steps in manufacturing rec ... more »
    • Financial Focus

      • CancerVax' Stock Rises with Merger
      • The stock price for CancerVax (www. has been rising steadily this year and changed by +19.70% from its close in the second week of February, prompting Zacks ( drugs analyst Chris Kallos to make a buy recommendation on th ... more »


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

The Triple Package and Success

One theory for explaining “success," put forward by Amy Chua Jed Rubenfeld, posits cultural traits such as a superiority complex, personal insecurity and impulse control. Union College professors Joshua Hart and Christopher Chabris counter that intelligence, conscientiousness, and economic advantage are the most likely elements of success, regardless of ethnicity. Do you think that Hart-Chabris make a better argument for achieving success than the Chua-Rubenfeld theory?

More »